Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma
Journal of Ocular Pharmacology and Therapeutics · 2025
DOI: 10.1089/jop.2025.0085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2025. Verfasst von Archana Padmanabhan Nair und 8 weiteren Autor:innen. Beteiligte Einrichtung: GROW Research Lab, Narayana Netralaya Foundation, Bangalore, India. Hauptthemen laut MEDLINE: Interferon-beta, Aqueous Humor, Glaucoma, Open-Angle, Glaucoma, Angle-Closure. Die Arbeit nennt 80 Literaturangaben.
Abstract (Originalsprache)
Purpose
Glaucoma, a neurodegenerative condition of the optic nerve is driven by increased intraocular pressure (IOP) due to fibrotic changes of the trabecular meshwork (TM). Interferon beta (IFN-β), a pleiotropic cytokine is known for its neuroprotective and antifibrotic potential. Hence, we investigated the intraocular status of IFN-β in patients with primary glaucoma.
Methods
Aqueous humor (AqH) from patients with primary glaucoma [107 eyes; primary open-angle glaucoma (POAG), 59 eyes; primary angle-closure glaucoma (PACG), 48 eyes] and controls (70 eyes) were collected during cataract surgery and/or trabeculectomy. TM from patients with POAG (20 eyes) and PACG (18 eyes) was collected during trabeculectomy. IFN-β in AqH was measured using bead-based Enzyme-Linked Immunosorbent Assay (ELISA), and messenger RNA (mRNA) expression of IFN-β in TM was measured by quantitative PCR.
Results
AqH-IFN-β levels were significantly (P < 0.05) lower in patients with glaucoma, particularly in patients with POAG compared with controls (area under the receiver operating characteristic curve = 0.723, P < 0.001; odds ratio of 5.1, P < 0.0001). AqH-IFN-β levels correlated positively with visual field index of both patients with POAG (r = 0.307; P = 0.0321) and PACG (r = 0.518; P = 0.0007). Whereas, AqH-IFN-β levels correlated positively with retinal nerve fiber layer thickness in patients with POAG (r = 0.460; P = 0.0042) only. TM-IFN-β mRNA expression was significantly lower in glaucoma patients with poor IOP control compared with those with good IOP control by IOP-lowering medications.
Conclusion
Lower IFN-β in AqH and TM of patients with glaucoma and its association with clinical indices suggests its neuroprotective and antifibrotic role in glaucoma. The findings highlight the potential for IFN-β-based prognostication and therapy in the management of glaucoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GROW Research Lab, Narayana Netralaya Foundation, Bangalore, India.
- Manipal Academy of Higher Education, Manipal, India.
- Narayana Nethralaya Eye Hospital, Bangalore, India.
ORCID-Profile: Arkasubhra Ghosh
Zitieren
APA
Padmanabhan Nair, A., Machiraju, P., Tejwani, S., Dinakaran, S., A V, S. D., Shetty, N., Shetty, R., Ghosh, A., & Sethu, S. (2025). Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2025.0085
Vancouver
Padmanabhan Nair A, Machiraju P, Tejwani S, Dinakaran S, A V SD, Shetty N, et al. Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 2025. doi:10.1089/jop.2025.0085
BibTeX
@article{PadmanabhanNair2025,
author = {Padmanabhan Nair, Archana and Machiraju, Praveen and Tejwani, Sushma and Dinakaran, Shoruba and A V, Sathi Devi and Shetty, Naren and Shetty, Rohit and Ghosh, Arkasubhra and Sethu, Swaminathan},
title = {Lower Levels of Endogenous Intraocular Interferon Beta in Patients with Primary Glaucoma},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2025},
doi = {10.1089/jop.2025.0085}
}
EUVIMED